Status:
COMPLETED
Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers?
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this randomized controlled study determine the efficacy of calorie restriction intermittent fasting diet in metabolic parameters and weight management among metabolic syndromes adults. It w...
Detailed Description
Aim The aim of this study; determine the efficacy of calorie restriction intermittent fasting diet in metabolic parameters and weight management among metabolic syndromes adults. Subjects Participant...
Eligibility Criteria
Inclusion
- Being between the ages of 18-65
- Body mass index to be 27 and above
- Clinical diagnosis of metabolic syndrome according to the criteria of IDF 2005 or NCP ATP III.
Exclusion
- Being in the pre-menopausal or menopause
- Following a special diet (such as Celiac, Type 1 diabetes)
- Using a special nutritional supplement (omega 3, probiotic, vitamin-mineral, teff seed etc.)
- Those who do not comply with the diet, pregnant, being lactating
- Doing heavy physical activity or working in a heavy job
- Presence of liver, kidney or immune deficiency
- Conditions that will seriously affect weight management such as having bariatric surgery
- Determined to have had an unintentional sudden weight loss of more than 5% in the last three months
- Not be practicing Muslim Ramadan fasting or had changed their dietary pattern 12 weeks before the study
Key Trial Info
Start Date :
January 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04502329
Start Date
January 30 2019
End Date
June 10 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University
Istanbul, Turkey (Türkiye)